These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 18214854)
1. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis. Creytens D; Van Gorp J; Speel EJ; Ferdinande L Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836 [TBL] [Abstract][Full Text] [Related]
3. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942 [TBL] [Abstract][Full Text] [Related]
4. [Clinical value of fluorescence Wang W; Li X; Liu P; Dong Y Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132 [TBL] [Abstract][Full Text] [Related]
5. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas? Italiano A; Cardot N; Dupré F; Monticelli I; Keslair F; Piche M; Mainguené C; Coindre JM; Pedeutour F Int J Cancer; 2007 Jul; 121(2):308-15. PubMed ID: 17372913 [TBL] [Abstract][Full Text] [Related]
6. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall. Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315 [TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521 [TBL] [Abstract][Full Text] [Related]
8. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma. Segura-Sánchez J; González-Cámpora R; Pareja-Megia MJ; García-Escudero A; Galera-Ruiz H; López-Beltrán A Anticancer Res; 2006; 26(6C):4937-42. PubMed ID: 17214366 [TBL] [Abstract][Full Text] [Related]
9. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases. Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP Mod Pathol; 2024 Jun; 37(6):100494. PubMed ID: 38621503 [TBL] [Abstract][Full Text] [Related]
10. A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions. Pedeutour F; Maire G; Pierron A; Thomas DM; Garsed DW; Bianchini L; Duranton-Tanneur V; Cortes-Maurel A; Italiano A; Squire JA; Coindre JM Virchows Arch; 2012 Jul; 461(1):67-78. PubMed ID: 22678079 [TBL] [Abstract][Full Text] [Related]
11. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma. Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861 [TBL] [Abstract][Full Text] [Related]
12. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346 [TBL] [Abstract][Full Text] [Related]
13. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours. Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100 [TBL] [Abstract][Full Text] [Related]
14. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477 [TBL] [Abstract][Full Text] [Related]
15. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706 [TBL] [Abstract][Full Text] [Related]
16. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas. Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885 [TBL] [Abstract][Full Text] [Related]
18. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978 [TBL] [Abstract][Full Text] [Related]
19. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]